FDA Approves Trial Of Self-Amplifying Bird Flu Vaccine Funded By Gates

Arcturus says the vaccine is “formulated within a lipid nanoparticle” and “is designed to make many copies of mRNA within the host cell.” This enables “lower doses than conventional mRNA vaccines.” Hulscher said the replication machinery of self-amplifying vaccines behaves “like a synthetic virus” and “allows for an unknown period of toxic antigen production.” Writing on Substack, immunologist and biochemist Jessica Rose, Ph.D., said the new vaccine has “major red flags.” She told The Defender, “Self-amplifying mRNA products should not be used.

“After the rollout of the first global genetic experiment with mRNA technology … it seems unbelievable that an even more aggressive attack on our body and genetics should be tried out.” On Substack, Rose wrote that self-amplifying vaccines are genetically modified, as “the coding template is a modified Alphavirus [a type of RNA virus] genome with the virus sub-genomic bits spiked out and the spike gene ‘spiked in.’” “Use of GMOs [genetically modified organisms] require specific licensing application and procedures,” Rose wrote, questioning whether this is the case for self-amplifying vaccines.

Epidemiologist Nicolas Hulscher told The Defender the FDA’s notification “means Arcturus Therapeutics can begin its “experiment of injecting humans with H5N1 bird flu replicon mRNA.” Self-amplifying mRNA injections contain an enzyme that instructs the body on how to make more mRNA.

With self-replication it can become immortal, forever antagonizing your — or your fetus’ — immune system with antigens.” Christof Plothe, D.O., a member of the World Council for Health steering committee, questioned the introduction of self-amplifying mRNA vaccines amid ongoing safety concerns about conventional mRNA shots. 

https://thepeoplesvoice.tv/fda-approves-trial-of-self-amplifying-bird-flu-vaccine-funded-by-gates/